Subscribe To
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference
LOS ALTOS, Calif., July 20, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that Shalabh Gupta, M.D., Chief Executive Officer will participate in a fireside chat at the H.C. Wainwright 2nd Annual Kidney Conference “Glomerular Disease: IgAN Is […] The post Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Con...
Read More
Posted: Jul 20 2023, 11:03
Author Name: forextv
Views: 080972